TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 161 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2016. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $5,724,000 | -39.3% | 58,509 | -28.5% | 0.16% | +18.8% |
| Q2 2018 | $9,428,000 | +133.5% | 81,784 | +100.0% | 0.14% | +12.2% |
| Q1 2018 | $4,038,000 | -11.9% | 40,892 | +0.5% | 0.12% | -21.2% |
| Q3 2017 | $4,583,000 | +0.5% | 40,673 | 0.0% | 0.16% | -1.3% |
| Q2 2017 | $4,558,000 | -2.0% | 40,673 | +2.0% | 0.16% | -7.1% |
| Q1 2017 | $4,651,000 | +24.0% | 39,885 | +11.9% | 0.17% | +21.4% |
| Q4 2016 | $3,751,000 | +13.2% | 35,633 | +18.8% | 0.14% | +12.0% |
| Q3 2016 | $3,315,000 | -24.1% | 30,000 | 0.0% | 0.12% | -25.1% |
| Q2 2016 | $4,368,000 | +1.6% | 30,000 | 0.0% | 0.17% | +2.5% |
| Q1 2016 | $4,298,000 | -7.3% | 30,000 | 0.0% | 0.16% | -4.1% |
| Q4 2015 | $4,637,000 | +8.2% | 30,000 | 0.0% | 0.17% | +1.2% |
| Q3 2015 | $4,287,000 | -50.3% | 30,000 | -50.0% | 0.17% | +8.4% |
| Q2 2015 | $8,622,000 | +103.8% | 60,000 | +100.0% | 0.16% | +5.4% |
| Q1 2015 | $4,231,000 | – | 30,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 565,951 | $24,483,000 | 8.44% |
| Murchinson Ltd. | 162,703 | $7,039,000 | 1.34% |
| Eversept Partners, LP | 220,286 | $9,529,572 | 0.73% |
| BRANDES INVESTMENT PARTNERS, LP | 379,322 | $16,410,000 | 0.35% |
| Analyst IMS Investment Management Services Ltd. | 17,657 | $764,000 | 0.07% |
| Claret Asset Management Corp | 7,279 | $315,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 326,427 | $14,086,000 | 0.06% |
| Renaissance Technologies | 678,300 | $29,343,000 | 0.03% |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 191,820 | $8,298,000 | 0.03% |
| ARK Investment Management | 55,566 | $2,404,000 | 0.01% |